Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004169HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10006529HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013404HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013405HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013406HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013407HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013408HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013409HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013410HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013411HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB09076
Drug NameUmeclidinium
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs23435542
CitationsSalmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ, Slack RJ, Sarau HM, Palovich MR, Laine DI, Hay DW, Rumsey WL: Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases. J Pharmacol Exp Ther. 2013 May;345(2):260-70. doi: 10.1124/jpet.112.202051. Epub 2013 Feb 22.
GroupsApproved
Direct ClassificationDiphenylmethanes
SMILESOC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
Pathways
PharmGKB
ChEMBLCHEMBL1187833